Opus Genetics (IRD) Assets Average (2011 - 2026)

Opus Genetics (IRD) has 16 years of Assets Average data on file, last reported at $58.5 million in Q1 2026.

• Quarterly Assets Average rose 37.64% year-over-year to $58.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.5 million (up 37.64% YoY) and the FY2025 annual result came in at $43.6 million, down 4.08% from the prior year.
• Assets Average climbed to $58.5 million in Q1 2026 per IRD's latest filing, from $43.2 million in the prior quarter.
• Across five years, Assets Average topped out at $58.5 million in Q1 2026 and bottomed at $16.2 million in Q3 2022.
• The 5-year median for Assets Average is $43.2 million (2025), against an average of $40.7 million.
• The widest annual swing landed in 2022, when Assets Average slumped 33.0%; it then jumped 200.79% in 2023.
• Tracing IRD's Assets Average over 5 years: stood at $31.8 million in 2022, then surged by 70.14% to $54.1 million in 2023, then slipped by 28.56% to $38.6 million in 2024, then climbed by 11.8% to $43.2 million in 2025, then surged by 35.51% to $58.5 million in 2026.
• Per Business Quant, the three latest IRD Assets Average figures stand at $58.5 million (Q1 2026), $43.2 million (Q4 2025), and $37.4 million (Q3 2025).

Peer Comparison